Tag
NYSE: PFE
- Moderna reports US$162M quarterly profit and raises sales outlook
- Pfizer raises sales outlook to US$62B to US$64B
- Cullinan Therapeutics gains FDA clearance for velinotamig blood-disorder trial
- Pfizer's ELREXFIO beats standard regimens in Phase 3 myeloma trial
- Enanta Pharmaceuticals starts late-stage RSV trial with 2027 data due
- Pfizer details 25‑strain infant vaccine data as pivotal trials advance
- Novo Nordisk A/S says FDA extends denecimig review over facility remediation
- Pfizer Inc details 61% EASI‑75 response in tilrekimig trial
- Eli Lilly and Company wins FDA pediatric Olumiant approval for severe alopecia
- Lung cancer innovations showcased at ASCO 2026 as researchers pursue earlier detection
- Oxford Biodynamics surges after Pfizer trial backs blood-based cancer test
- Australian biotech uncovers broader view of tumour genetics with liquid biopsy
- University of Waterloo and Princess Margaret Cancer Centre collaborate on innovative cancer research
- NetraMark demonstrates efficacy of AI to help with clinical trials